Next Quarterly Earnings
Thursday, November 5, 2026
CW 45
Pre-Market
In 70 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Edgewise Therapeutics
Edgewise Therapeutics is a US-based biotechnology company specializing in the development of innovative therapies for rare muscle disorders. The company focuses on small-molecule compounds designed to target and improve muscle function in patients suffering from Duchenne muscular dystrophy.
Frequently asked questions
When will Edgewise Therapeutics report its next quarterly earnings?
Edgewise Therapeutics is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Edgewise Therapeutics last report quarterly earnings?
Edgewise Therapeutics last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.53 USD.
How often has Edgewise Therapeutics beaten expectations?
Edgewise Therapeutics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
How do I add the Edgewise Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
3/5
Quarters above estimates
60%
Beat rate
-3.2%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Edgewise Therapeutics
Country
🇺🇸
More Financial Information